APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucosamine and Chondroitin Sulfate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glucosamine and Chondroitin Sulfate Market Outlook and Growth Opportunities 2026

21 December 2025209 pages

Choose your research edition.

Industry ResearchGlucosamine and Chondroitin Sulfate Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucosamine and Chondroitin Sulfate Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Glucosamine and Chondroitin Sulfate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucosamine and Chondroitin Sulfate Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucosamine and Chondroitin Sulfate Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Glucosamine and Chondroitin Sulfate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucosamine and Chondroitin Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glucosamine and Chondroitin Sulfate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glucosamine and Chondroitin Sulfate market include ANXIN, Yantai Dongcheng, Runxin Biotechnology, WanTuMing Biological, Hengjie Bio-Pharmaceuticals, YBCC, TSI Group, Summit Nutritionals International and Summit Nutritionals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucosamine and Chondroitin Sulfate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucosamine and Chondroitin Sulfate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucosamine and Chondroitin Sulfate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucosamine and Chondroitin Sulfate market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucosamine and Chondroitin Sulfate Segment by Company

ANXIN

Yantai Dongcheng

Runxin Biotechnology

WanTuMing Biological

Hengjie Bio-Pharmaceuticals

YBCC

TSI Group

Summit Nutritionals International

Summit Nutritionals

Sioux Pharm

Ruikangda Biochemical

QJBCHINA

Pacific Rainbow

Nippon Zoki

Meitek (Synutra International)

ISBA

Huiwen

Guanglong Biochem

GGI

Focus Chem

Glucosamine and Chondroitin Sulfate Segment by Type

Food Grade Glucosamine and Chondroitin Sulfate

Pharmaceutical Grade Glucosamine and Chondroitin Sulfate

Glucosamine and Chondroitin Sulfate Segment by Application

Cosmetics

Dietary Supplements

Pharmaceutical

Others

Glucosamine and Chondroitin Sulfate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glucosamine and Chondroitin Sulfate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucosamine and Chondroitin Sulfate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucosamine and Chondroitin Sulfate significant trends, drivers, influence factors in global and regions.

6. To analyze Glucosamine and Chondroitin Sulfate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosamine and Chondroitin Sulfate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucosamine and Chondroitin Sulfate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosamine and Chondroitin Sulfate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucosamine and Chondroitin Sulfate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucosamine and Chondroitin Sulfate industry.

Chapter 3: Detailed analysis of Glucosamine and Chondroitin Sulfate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucosamine and Chondroitin Sulfate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucosamine and Chondroitin Sulfate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucosamine and Chondroitin Sulfate Industry Trends Table 2. Glucosamine and Chondroitin Sulfate Industry Drivers Table 3. Glucosamine and Chondroitin Sulfate Industry Opportunities and Challenges Table 4. Glucosamine and Chondroitin Sulfate Industry Restraints Table 5. Global Glucosamine and Chondroitin Sulfate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucosamine and Chondroitin Sulfate Revenue Share by Company (2021-2026) Table 7. Global Glucosamine and Chondroitin Sulfate Sales Volume by Company (k units) & (2021-2026) Table 8. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Company (2021-2026) Table 9. Global Glucosamine and Chondroitin Sulfate Average Price (US$/unit) of Company (2021-2026) Table 10. Global Glucosamine and Chondroitin Sulfate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucosamine and Chondroitin Sulfate Key Company Manufacturing Base & Headquarters Table 12. Global Glucosamine and Chondroitin Sulfate Company, Product Type & Application Table 13. Global Glucosamine and Chondroitin Sulfate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucosamine and Chondroitin Sulfate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Glucosamine and Chondroitin Sulfate Table 18. Significant Companies of Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Table 19. Global Glucosamine and Chondroitin Sulfate Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Glucosamine and Chondroitin Sulfate Sales Volume by Type (2021-2026) & (k units) Table 21. Global Glucosamine and Chondroitin Sulfate Sales Volume by Type (2027-2032) & (k units) Table 22. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Type (2021-2026) Table 23. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Type (2027-2032) Table 24. Global Glucosamine and Chondroitin Sulfate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glucosamine and Chondroitin Sulfate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glucosamine and Chondroitin Sulfate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Type (2021-2026) Table 28. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cosmetics Table 30. Significant Companies of Dietary Supplements Table 31. Significant Companies of Pharmaceutical Table 32. Significant Companies of Others Table 33. Global Glucosamine and Chondroitin Sulfate Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Glucosamine and Chondroitin Sulfate Sales Volume by Application (2021-2026) & (k units) Table 35. Global Glucosamine and Chondroitin Sulfate Sales Volume by Application (2027-2032) & (k units) Table 36. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Application (2021-2026) Table 37. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Application (2027-2032) Table 38. Global Glucosamine and Chondroitin Sulfate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Glucosamine and Chondroitin Sulfate Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Glucosamine and Chondroitin Sulfate Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Application (2021-2026) Table 42. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Application (2027-2032) Table 43. Global Glucosamine and Chondroitin Sulfate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Glucosamine and Chondroitin Sulfate Sales by Region (2021-2026) & (k units) Table 45. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2021-2026) Table 46. Global Glucosamine and Chondroitin Sulfate Sales by Region (2027-2032) & (k units) Table 47. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2027-2032) Table 48. Global Glucosamine and Chondroitin Sulfate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Glucosamine and Chondroitin Sulfate Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Region (2021-2026) Table 51. Global Glucosamine and Chondroitin Sulfate Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Region (2027-2032) Table 53. Global Glucosamine and Chondroitin Sulfate Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Glucosamine and Chondroitin Sulfate Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Glucosamine and Chondroitin Sulfate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026) & (k units) Table 58. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2021-2026) Table 59. Global Glucosamine and Chondroitin Sulfate Sales by Country (2027-2032) & (k units) Table 60. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2027-2032) Table 61. Global Glucosamine and Chondroitin Sulfate Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Glucosamine and Chondroitin Sulfate Sales Value Market Share by Country (2021-2026) Table 63. Global Glucosamine and Chondroitin Sulfate Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Glucosamine and Chondroitin Sulfate Sales Value Market Share by Country (2027-2032) Table 65. ANXIN Company Information Table 66. ANXIN Business Overview Table 67. ANXIN Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. ANXIN Glucosamine and Chondroitin Sulfate Product Portfolio Table 69. ANXIN Recent Development Table 70. Yantai Dongcheng Company Information Table 71. Yantai Dongcheng Business Overview Table 72. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product Portfolio Table 74. Yantai Dongcheng Recent Development Table 75. Runxin Biotechnology Company Information Table 76. Runxin Biotechnology Business Overview Table 77. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product Portfolio Table 79. Runxin Biotechnology Recent Development Table 80. WanTuMing Biological Company Information Table 81. WanTuMing Biological Business Overview Table 82. WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. WanTuMing Biological Glucosamine and Chondroitin Sulfate Product Portfolio Table 84. WanTuMing Biological Recent Development Table 85. Hengjie Bio-Pharmaceuticals Company Information Table 86. Hengjie Bio-Pharmaceuticals Business Overview Table 87. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product Portfolio Table 89. Hengjie Bio-Pharmaceuticals Recent Development Table 90. YBCC Company Information Table 91. YBCC Business Overview Table 92. YBCC Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. YBCC Glucosamine and Chondroitin Sulfate Product Portfolio Table 94. YBCC Recent Development Table 95. TSI Group Company Information Table 96. TSI Group Business Overview Table 97. TSI Group Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. TSI Group Glucosamine and Chondroitin Sulfate Product Portfolio Table 99. TSI Group Recent Development Table 100. Summit Nutritionals International Company Information Table 101. Summit Nutritionals International Business Overview Table 102. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product Portfolio Table 104. Summit Nutritionals International Recent Development Table 105. Summit Nutritionals Company Information Table 106. Summit Nutritionals Business Overview Table 107. Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Summit Nutritionals Glucosamine and Chondroitin Sulfate Product Portfolio Table 109. Summit Nutritionals Recent Development Table 110. Sioux Pharm Company Information Table 111. Sioux Pharm Business Overview Table 112. Sioux Pharm Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Sioux Pharm Glucosamine and Chondroitin Sulfate Product Portfolio Table 114. Sioux Pharm Recent Development Table 115. Ruikangda Biochemical Company Information Table 116. Ruikangda Biochemical Business Overview Table 117. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product Portfolio Table 119. Ruikangda Biochemical Recent Development Table 120. QJBCHINA Company Information Table 121. QJBCHINA Business Overview Table 122. QJBCHINA Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. QJBCHINA Glucosamine and Chondroitin Sulfate Product Portfolio Table 124. QJBCHINA Recent Development Table 125. Pacific Rainbow Company Information Table 126. Pacific Rainbow Business Overview Table 127. Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Pacific Rainbow Glucosamine and Chondroitin Sulfate Product Portfolio Table 129. Pacific Rainbow Recent Development Table 130. Nippon Zoki Company Information Table 131. Nippon Zoki Business Overview Table 132. Nippon Zoki Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Nippon Zoki Glucosamine and Chondroitin Sulfate Product Portfolio Table 134. Nippon Zoki Recent Development Table 135. Meitek (Synutra International) Company Information Table 136. Meitek (Synutra International) Business Overview Table 137. Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Product Portfolio Table 139. Meitek (Synutra International) Recent Development Table 140. ISBA Company Information Table 141. ISBA Business Overview Table 142. ISBA Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. ISBA Glucosamine and Chondroitin Sulfate Product Portfolio Table 144. ISBA Recent Development Table 145. Huiwen Company Information Table 146. Huiwen Business Overview Table 147. Huiwen Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Huiwen Glucosamine and Chondroitin Sulfate Product Portfolio Table 149. Huiwen Recent Development Table 150. Guanglong Biochem Company Information Table 151. Guanglong Biochem Business Overview Table 152. Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Guanglong Biochem Glucosamine and Chondroitin Sulfate Product Portfolio Table 154. Guanglong Biochem Recent Development Table 155. GGI Company Information Table 156. GGI Business Overview Table 157. GGI Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 158. GGI Glucosamine and Chondroitin Sulfate Product Portfolio Table 159. GGI Recent Development Table 160. Focus Chem Company Information Table 161. Focus Chem Business Overview Table 162. Focus Chem Glucosamine and Chondroitin Sulfate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 163. Focus Chem Glucosamine and Chondroitin Sulfate Product Portfolio Table 164. Focus Chem Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Glucosamine and Chondroitin Sulfate Distributors List Table 168. Glucosamine and Chondroitin Sulfate Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Glucosamine and Chondroitin Sulfate Product Image Figure 2. Global Glucosamine and Chondroitin Sulfate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucosamine and Chondroitin Sulfate Sales (2021-2032) & (k units) Figure 5. Global Glucosamine and Chondroitin Sulfate Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Glucosamine and Chondroitin Sulfate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Glucosamine and Chondroitin Sulfate Image Figure 10. Pharmaceutical Grade Glucosamine and Chondroitin Sulfate Image Figure 11. Global Glucosamine and Chondroitin Sulfate Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Glucosamine and Chondroitin Sulfate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Type (2021-2032) Figure 14. Global Glucosamine and Chondroitin Sulfate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glucosamine and Chondroitin Sulfate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Type (2021-2032) Figure 17. Cosmetics Image Figure 18. Dietary Supplements Image Figure 19. Pharmaceutical Image Figure 20. Others Image Figure 21. Global Glucosamine and Chondroitin Sulfate Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Glucosamine and Chondroitin Sulfate Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Application (2021-2032) Figure 24. Global Glucosamine and Chondroitin Sulfate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Glucosamine and Chondroitin Sulfate Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Application (2021-2032) Figure 27. Global Glucosamine and Chondroitin Sulfate Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Glucosamine and Chondroitin Sulfate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Glucosamine and Chondroitin Sulfate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 32. North America Glucosamine and Chondroitin Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Glucosamine and Chondroitin Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 38. South America Glucosamine and Chondroitin Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Glucosamine and Chondroitin Sulfate Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Glucosamine and Chondroitin Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Glucosamine and Chondroitin Sulfate Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Glucosamine and Chondroitin Sulfate Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade Glucosamine and Chondroitin Sulfate
  • Pharmaceutical Grade Glucosamine and Chondroitin Sulfate
Applications
  • Cosmetics
  • Dietary Supplements
  • Pharmaceutical
  • Others
Companies covered
  • ANXIN
  • Yantai Dongcheng
  • Runxin Biotechnology
  • WanTuMing Biological
  • Hengjie Bio-Pharmaceuticals
  • YBCC
  • TSI Group
  • Summit Nutritionals International
  • Summit Nutritionals
  • Sioux Pharm
  • Ruikangda Biochemical
  • QJBCHINA
  • Pacific Rainbow
  • Nippon Zoki
  • Meitek (Synutra International)
  • ISBA
  • Huiwen
  • Guanglong Biochem
  • GGI
  • Focus Chem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  4. 1.2.2 Global Glucosamine and Chondroitin Sulfate Sales Volume (2021-2032)
  5. 1.2.3 Global Glucosamine and Chondroitin Sulfate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucosamine and Chondroitin Sulfate Market Dynamics
  1. 2.1 Glucosamine and Chondroitin Sulfate Industry Trends
  2. 2.2 Glucosamine and Chondroitin Sulfate Industry Drivers
  3. 2.3 Glucosamine and Chondroitin Sulfate Industry Opportunities and Challenges
  4. 2.4 Glucosamine and Chondroitin Sulfate Industry Restraints
3 Glucosamine and Chondroitin Sulfate Market by Company
  1. 3.1 Global Glucosamine and Chondroitin Sulfate Company Revenue Ranking in 2025
  2. 3.2 Global Glucosamine and Chondroitin Sulfate Revenue by Company (2021-2026)
  3. 3.3 Global Glucosamine and Chondroitin Sulfate Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucosamine and Chondroitin Sulfate Average Price by Company (2021-2026)
  5. 3.5 Global Glucosamine and Chondroitin Sulfate Company Ranking (2024-2026)
  6. 3.6 Global Glucosamine and Chondroitin Sulfate Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucosamine and Chondroitin Sulfate Company Product Type and Application
  8. 3.8 Global Glucosamine and Chondroitin Sulfate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucosamine and Chondroitin Sulfate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucosamine and Chondroitin Sulfate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucosamine and Chondroitin Sulfate Market by Type
  1. 4.1 Glucosamine and Chondroitin Sulfate Type Introduction
  2. 4.1.1 Food Grade Glucosamine and Chondroitin Sulfate
  3. 4.1.2 Pharmaceutical Grade Glucosamine and Chondroitin Sulfate
  4. 4.2 Global Glucosamine and Chondroitin Sulfate Sales Volume by Type
  5. 4.2.1 Global Glucosamine and Chondroitin Sulfate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glucosamine and Chondroitin Sulfate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glucosamine and Chondroitin Sulfate Sales Value by Type
  9. 4.3.1 Global Glucosamine and Chondroitin Sulfate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glucosamine and Chondroitin Sulfate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glucosamine and Chondroitin Sulfate Sales Value Share by Type (2021-2032)
5 Glucosamine and Chondroitin Sulfate Market by Application
  1. 5.1 Glucosamine and Chondroitin Sulfate Application Introduction
  2. 5.1.1 Cosmetics
  3. 5.1.2 Dietary Supplements
  4. 5.1.3 Pharmaceutical
  5. 5.1.4 Others
  6. 5.2 Global Glucosamine and Chondroitin Sulfate Sales Volume by Application
  7. 5.2.1 Global Glucosamine and Chondroitin Sulfate Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Glucosamine and Chondroitin Sulfate Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Glucosamine and Chondroitin Sulfate Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Glucosamine and Chondroitin Sulfate Sales Value by Application
  11. 5.3.1 Global Glucosamine and Chondroitin Sulfate Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Glucosamine and Chondroitin Sulfate Sales Value by Application (2021-2032)
  13. 5.3.3 Global Glucosamine and Chondroitin Sulfate Sales Value Share by Application (2021-2032)
6 Glucosamine and Chondroitin Sulfate Regional Sales and Value Analysis
  1. 6.1 Global Glucosamine and Chondroitin Sulfate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucosamine and Chondroitin Sulfate Sales by Region (2021-2032)
  3. 6.2.1 Global Glucosamine and Chondroitin Sulfate Sales by Region: 2021-2026
  4. 6.2.2 Global Glucosamine and Chondroitin Sulfate Sales by Region (2027-2032)
  5. 6.3 Global Glucosamine and Chondroitin Sulfate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucosamine and Chondroitin Sulfate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucosamine and Chondroitin Sulfate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucosamine and Chondroitin Sulfate Sales Value by Region (2027-2032)
  9. 6.5 Global Glucosamine and Chondroitin Sulfate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  12. 6.6.2 North America Glucosamine and Chondroitin Sulfate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  15. 6.7.2 Europe Glucosamine and Chondroitin Sulfate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucosamine and Chondroitin Sulfate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  21. 6.9.2 South America Glucosamine and Chondroitin Sulfate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucosamine and Chondroitin Sulfate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucosamine and Chondroitin Sulfate Sales Value Share by Country, 2025 VS 2032
7 Glucosamine and Chondroitin Sulfate Country-level Sales and Value Analysis
  1. 7.1 Global Glucosamine and Chondroitin Sulfate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucosamine and Chondroitin Sulfate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucosamine and Chondroitin Sulfate Sales by Country (2021-2032)
  4. 7.3.1 Global Glucosamine and Chondroitin Sulfate Sales by Country (2021-2026)
  5. 7.3.2 Global Glucosamine and Chondroitin Sulfate Sales by Country (2027-2032)
  6. 7.4 Global Glucosamine and Chondroitin Sulfate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucosamine and Chondroitin Sulfate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucosamine and Chondroitin Sulfate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucosamine and Chondroitin Sulfate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucosamine and Chondroitin Sulfate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucosamine and Chondroitin Sulfate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ANXIN
  2. 8.1.1 ANXIN Company Information
  3. 8.1.2 ANXIN Business Overview
  4. 8.1.3 ANXIN Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ANXIN Glucosamine and Chondroitin Sulfate Product Portfolio
  6. 8.1.5 ANXIN Recent Developments
  7. 8.2 Yantai Dongcheng
  8. 8.2.1 Yantai Dongcheng Company Information
  9. 8.2.2 Yantai Dongcheng Business Overview
  10. 8.2.3 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Product Portfolio
  12. 8.2.5 Yantai Dongcheng Recent Developments
  13. 8.3 Runxin Biotechnology
  14. 8.3.1 Runxin Biotechnology Company Information
  15. 8.3.2 Runxin Biotechnology Business Overview
  16. 8.3.3 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Product Portfolio
  18. 8.3.5 Runxin Biotechnology Recent Developments
  19. 8.4 WanTuMing Biological
  20. 8.4.1 WanTuMing Biological Company Information
  21. 8.4.2 WanTuMing Biological Business Overview
  22. 8.4.3 WanTuMing Biological Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WanTuMing Biological Glucosamine and Chondroitin Sulfate Product Portfolio
  24. 8.4.5 WanTuMing Biological Recent Developments
  25. 8.5 Hengjie Bio-Pharmaceuticals
  26. 8.5.1 Hengjie Bio-Pharmaceuticals Company Information
  27. 8.5.2 Hengjie Bio-Pharmaceuticals Business Overview
  28. 8.5.3 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Product Portfolio
  30. 8.5.5 Hengjie Bio-Pharmaceuticals Recent Developments
  31. 8.6 YBCC
  32. 8.6.1 YBCC Company Information
  33. 8.6.2 YBCC Business Overview
  34. 8.6.3 YBCC Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 YBCC Glucosamine and Chondroitin Sulfate Product Portfolio
  36. 8.6.5 YBCC Recent Developments
  37. 8.7 TSI Group
  38. 8.7.1 TSI Group Company Information
  39. 8.7.2 TSI Group Business Overview
  40. 8.7.3 TSI Group Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 TSI Group Glucosamine and Chondroitin Sulfate Product Portfolio
  42. 8.7.5 TSI Group Recent Developments
  43. 8.8 Summit Nutritionals International
  44. 8.8.1 Summit Nutritionals International Company Information
  45. 8.8.2 Summit Nutritionals International Business Overview
  46. 8.8.3 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Summit Nutritionals International Glucosamine and Chondroitin Sulfate Product Portfolio
  48. 8.8.5 Summit Nutritionals International Recent Developments
  49. 8.9 Summit Nutritionals
  50. 8.9.1 Summit Nutritionals Company Information
  51. 8.9.2 Summit Nutritionals Business Overview
  52. 8.9.3 Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Summit Nutritionals Glucosamine and Chondroitin Sulfate Product Portfolio
  54. 8.9.5 Summit Nutritionals Recent Developments
  55. 8.10 Sioux Pharm
  56. 8.10.1 Sioux Pharm Company Information
  57. 8.10.2 Sioux Pharm Business Overview
  58. 8.10.3 Sioux Pharm Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sioux Pharm Glucosamine and Chondroitin Sulfate Product Portfolio
  60. 8.10.5 Sioux Pharm Recent Developments
  61. 8.11 Ruikangda Biochemical
  62. 8.11.1 Ruikangda Biochemical Company Information
  63. 8.11.2 Ruikangda Biochemical Business Overview
  64. 8.11.3 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Product Portfolio
  66. 8.11.5 Ruikangda Biochemical Recent Developments
  67. 8.12 QJBCHINA
  68. 8.12.1 QJBCHINA Company Information
  69. 8.12.2 QJBCHINA Business Overview
  70. 8.12.3 QJBCHINA Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 QJBCHINA Glucosamine and Chondroitin Sulfate Product Portfolio
  72. 8.12.5 QJBCHINA Recent Developments
  73. 8.13 Pacific Rainbow
  74. 8.13.1 Pacific Rainbow Company Information
  75. 8.13.2 Pacific Rainbow Business Overview
  76. 8.13.3 Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pacific Rainbow Glucosamine and Chondroitin Sulfate Product Portfolio
  78. 8.13.5 Pacific Rainbow Recent Developments
  79. 8.14 Nippon Zoki
  80. 8.14.1 Nippon Zoki Company Information
  81. 8.14.2 Nippon Zoki Business Overview
  82. 8.14.3 Nippon Zoki Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Nippon Zoki Glucosamine and Chondroitin Sulfate Product Portfolio
  84. 8.14.5 Nippon Zoki Recent Developments
  85. 8.15 Meitek (Synutra International)
  86. 8.15.1 Meitek (Synutra International) Company Information
  87. 8.15.2 Meitek (Synutra International) Business Overview
  88. 8.15.3 Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Product Portfolio
  90. 8.15.5 Meitek (Synutra International) Recent Developments
  91. 8.16 ISBA
  92. 8.16.1 ISBA Company Information
  93. 8.16.2 ISBA Business Overview
  94. 8.16.3 ISBA Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ISBA Glucosamine and Chondroitin Sulfate Product Portfolio
  96. 8.16.5 ISBA Recent Developments
  97. 8.17 Huiwen
  98. 8.17.1 Huiwen Company Information
  99. 8.17.2 Huiwen Business Overview
  100. 8.17.3 Huiwen Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Huiwen Glucosamine and Chondroitin Sulfate Product Portfolio
  102. 8.17.5 Huiwen Recent Developments
  103. 8.18 Guanglong Biochem
  104. 8.18.1 Guanglong Biochem Company Information
  105. 8.18.2 Guanglong Biochem Business Overview
  106. 8.18.3 Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Guanglong Biochem Glucosamine and Chondroitin Sulfate Product Portfolio
  108. 8.18.5 Guanglong Biochem Recent Developments
  109. 8.19 GGI
  110. 8.19.1 GGI Company Information
  111. 8.19.2 GGI Business Overview
  112. 8.19.3 GGI Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 GGI Glucosamine and Chondroitin Sulfate Product Portfolio
  114. 8.19.5 GGI Recent Developments
  115. 8.20 Focus Chem
  116. 8.20.1 Focus Chem Company Information
  117. 8.20.2 Focus Chem Business Overview
  118. 8.20.3 Focus Chem Glucosamine and Chondroitin Sulfate Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Focus Chem Glucosamine and Chondroitin Sulfate Product Portfolio
  120. 8.20.5 Focus Chem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucosamine and Chondroitin Sulfate Value Chain Analysis
  2. 9.1.1 Glucosamine and Chondroitin Sulfate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucosamine and Chondroitin Sulfate Sales Mode & Process
  6. 9.2 Glucosamine and Chondroitin Sulfate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucosamine and Chondroitin Sulfate Distributors
  9. 9.2.3 Glucosamine and Chondroitin Sulfate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst